Skip to search formSkip to main contentSkip to account menu

Antegren

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

natalizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Antegren: A Beacon of Hope (B)
2005
2005
Diversify to multiply
Nightmare scenarios Biotech investors can suffer two main nightmares apart from management misconduct. The first occurs when a… 
Review
2004
Review
2004
Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.
Natalizumab [AN 100226, anti-alpha4 integrin monoclonal antibody, Antegren] is a humanised monoclonal antibody that blocks… 
2004
2004
GLANCE: A double-blind, randomised, placebo-controlled, parallel-group safety study of natalizumab (Antegren) in combination with glatiramer acetate (Copaxone) in subjects with relapsing-remitting…
2004
2004
A phase III, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of antegren (Natalizumab) in maintaining clinical response and remission in Crohn’s disease (ENACT-2)
Review
2003
Review
2003
[Diagnosis and treatment of multiple sclerosis. Update, 2003].
Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. The etiology of MS is not yet… 
2003
2003
A Small Molecule α4β1/α4β7 Antagonist Differentiates between the Low-Affinity States of α4β1 and α4β7: Characterization of Divalent Cation Dependence
An α4β1/α4β7 dual antagonist, 35S-compound 1, was used as a model ligand to study the effect of divalent cations on the… 
2002
2002
Antegren (Natalizumab)Ein viel versprechender neuer Ansatz für die Therapie der Multiplen Sklerose
ZusammenfassungAntegren (Natalizumab) ist ein “humanisierter” monoklonaler Antikörper, der an die α4-Untereinheit von α4β1… 
2000
2000
Reduction of Relapses in Multiple Sclerosis after Anti-Alpha4 Integrin Antibody (Natalizumab)
Abstract Anti-alpha4 integrin antibody, natalizumab (Antegren), is a monoclonal antibody to a4b1 integrin adhesion molecules… 
1998
1998
Antegren Athena Neurosciences Inc.
  • M. Elices
  • IDrugs : the investigational drugs journal
  • 1998
  • Corpus ID: 37916434
AN-100226 (Antegren), a humanized monoclonal antibody (MAb) directed against the alpha4beta1 integrin (VLA-4) expressed on… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)